Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
41 studies found for:    Open Studies | "Papillomavirus Infections"
Show Display Options
Rank Status Study
21 Recruiting Avelumab for People With Recurrent Respiratory Papillomatosis
Conditions: Recurrent Respiratory Papillomatosis;   Juvenile Laryngeal Papilloma;   Laryngeal Papilloma, Recurrent;   Respiratory Papillomatosis;   Human Papilloma Virus
Intervention: Drug: Avelumab
22 Not yet recruiting Safety Study of EF-022 in Adults With Recurrent Respiratory Papillomatosis (RRP)
Condition: Recurrent Respiratory Papillomatosis
Intervention: Drug: EF-022 (Modified Vitamin D Binding Protein Macrophage Activator)
23 Recruiting Study of Anti-PD-1 Therapy for HPV-associated Recurrent Respiratory Papilloma Patients With Laryngeal, Tracheal and/or Pulmonary Involvement
Condition: Recurrent Respiratory Papillomatosis
Intervention: Drug: Pembrolizumab
24 Recruiting Bevacizumab Versus Cidofovir for the Treatment of Recurrent Respiratory Papillomatosis
Condition: Recurrent Respiratory Papillomatosis
Interventions: Drug: Bevacizumab;   Drug: Cidofovir;   Other: Placebo
25 Not yet recruiting 4-valent HPV Vaccine to Treat Recurrent Respiratory Papillomatosis in Children
Condition: Recurrent Respiratory Papillomatosis
Intervention: Biological: 4-valent HPV vaccine
26 Recruiting Recurrent Respiratory Papillomatosis and Extraesophageal Reflux
Conditions: Recurrent Respiratory Papillomatosis;   Extra Oesophageal Reflux;   Laryngeal Cyst
Interventions: Procedure: Surgical collection of histology specimen;   Procedure: Performance of immunohistochemical analysis
27 Recruiting A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma Patients
Condition: Condyloma
Interventions: Drug: AP611074 5% gel;   Drug: AP611074 matching placebo
28 Not yet recruiting A Phase 3 Study to Evaluate the Efficacy and Safety of CLS006 Versus Vehicle in Subjects 12 Years of Age or Older With Cutaneous Common Warts
Condition: Cutaneous Common Warts
Interventions: Drug: Furosemide Topical Gel;   Drug: Vehicle Topical Gel
29 Recruiting Biofields Therapy on Warts
Condition: Wart
Interventions: Other: True Biofield therapy;   Other: Fake Biofield therapy
30 Recruiting Exploratory Study of Efficacy and Safety of Ingenol Mebutate 0.05% Gel for Common Warts on the Hands.
Conditions: Verruca Vulgaris;   Common Warts
Intervention: Drug: ingenol mebutate 0.05% gel
31 Recruiting Nanopulse Efficacy Study for the Treatment of Common Warts
Condition: Common Warts
Intervention: Device: Nanopulse System
32 Recruiting Evaluate the Effectiveness and Safety of DPCP Ointment (Samcyprone™) on the Clearance of Verruca Vulgaris (Common Warts)
Conditions: Common Warts;   HPV (Human Papillomavirus);   Periungual Warts;   Plantar Warts
Interventions: Drug: Sensitizing DPCP Ointment;   Drug: Treatment DPCP Ointment
33 Recruiting Investigating Veregen ™ 15% Ointment Treatment For Non-facial Verrucae in Pediatric Patients: A Pilot Study
Condition: Verruca, Warts
Intervention: Drug: Veregen or Sinecatechins
34 Not yet recruiting Intralesional Cidofovir for the Treatment of Recalcitrant Warts in the Pediatric Immune-suppressed Population.
Condition: Warts
Intervention: Drug: Cidofovir
35 Recruiting Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Condition: Warts
Interventions: Biological: CANDIN;   Other: Placebo
36 Recruiting Safety and Efficacy Double Blind Vehicle Controlled Study of 15% AS101 Gel to Treat External Genital Warts
Condition: External Genital Warts
Interventions: Drug: 15% AS101 gel;   Drug: Vehicle
37 Recruiting Efficacy and Safety Profiles of SR-T100 Gel on External Genital Warts/Condyloma Acuminate(EGWs)
Conditions: Condyloma Acuminata;   Genital Warts;   Condylomata Acuminata;   Venereal Warts
Interventions: Drug: Vehicle gel;   Drug: SR-T100 gel with 1.0 % SM;   Drug: SR-T100 gel with 2.3% SM
38 Not yet recruiting Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients
Condition: Common Wart
Interventions: Drug: Vehicle gel;   Drug: SR-T100 gel with 1.0% of SM;   Drug: SR-T100 gel with 2.3% of SM
39 Recruiting Pharmacodynamics, Safety and Efficacy of Topical Omiganan in Patients With External Genital Warts
Condition: Condylomata Acuminata (External)
Interventions: Drug: Omiganan (CLS001) topical gel;   Drug: Vehicle topical gel
40 Recruiting Carbon Dioxide Laser vs. Electrocoagulation for the Therapy of Condyloma
Condition: Condylomata Acuminata
Interventions: Device: Carbon dioxide Laser ablation;   Device: Electrocoagulation

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-41) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.